Literature DB >> 23463134

Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Georgia Giannouli1, Chryssa Tzoumaka-Bakoula, Ioannis Kopsidas, Paraskevi Papadogeorgou, George P Chrousos, Athanasios Michos.   

Abstract

Kawasaki disease (KD) is an acute systemic vasculitis of childhood. The diagnosis is based on clinical criteria. However, the presentation of KD is incomplete/atypical for approximately 20 % of patients. Kawasaki disease is complicated with coronary artery lesions (CALs) and considered the most common cause of acquired heart disease in children. The medical records of children discharged with KD from a tertiary pediatric hospital in Athens, Greece, during a decade (2001-2010) were retrospectively analyzed. During the study period, KD was diagnosed for 86 children younger than 14 years of age. Complete diagnostic criteria were fulfilled by 64 of the children (74.4 %), whereas 25.6 % were considered incomplete cases. Cardiovascular complications were detected in 48 children (55.8 %) and CALs in 28 children (32.6 %). The prevalence of CALs did not differ significantly between complete and incomplete/atypical KD (42.2 vs 4.5 %; P = 0.001). Logistic regression analysis showed that erythema in the lips and oral cavity was associated with the development of CALs [odds ratio (OR), 3.03; 95 % confidence interval (CI), 1.051-8.783; P = 0.040]. Conversely, children with incomplete/atypical KD (OR, 0.092; 95 % CI, 0.010-0.816; P = 0.032) and previous antibiotic treatment (OR, 0.17; 95 % CI, 0.036-0.875; P = 0.034) were less likely to experience CALs. Children with an incomplete/atypical presentation of KD or before antibiotic treatment may be at lower risk for the development of CALs. Future multicenter studies may help to establish this association better.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463134     DOI: 10.1007/s00246-013-0673-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  34 in total

1.  Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Makiko Naka Mieno; Ritei Uehara; Keiji Tsuchiya; Tomoyoshi Sonobe; Yosikazu Nakamura
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

2.  Kawasaki disease in Greek children: a retrospective study.

Authors:  A Alexopoulos; A Vekiou; L Lycopoulou; A Tavena; E Lagona; T Kakourou
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-02-24       Impact factor: 6.166

3.  Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.

Authors:  Sunil J Ghelani; Craig Sable; Bernhard L Wiedermann; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

4.  Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease.

Authors:  Tarun Sabharwal; Cedric Manlhiot; Susanne M Benseler; Pascal N Tyrrell; Nita Chahal; Rae S M Yeung; Brian W McCrindle
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

5.  Clinical characteristics of Kawasaki disease according to age at diagnosis.

Authors:  Seong Hyun Kim; Ki Hwan Kim; Dong Soo Kim
Journal:  Indian Pediatr       Date:  2009-07       Impact factor: 1.411

6.  Management of Kawasaki disease in the British Isles.

Authors:  R Dhillon; L Newton; P T Rudd; S M Hall
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

7.  Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome.

Authors:  Donato Rigante; Piero Valentini; Daniela Rizzo; Andrea Leo; Gabriella De Rosa; Roberta Onesimo; Alessia De Nisco; Donatella Francesca Angelone; Adele Compagnone; Angelica Bibiana Delogu
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

8.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

Review 9.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

10.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Satoshi Tsuboi; Yasuko Aoyama; Kazuhiko Kotani; Enkh-Oyun Tsogzolbaatar; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

View more
  17 in total

1.  Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.

Authors:  Yunjia Tang; Wenhua Yan; Ling Sun; Jie Huang; Weiguo Qian; Yueyue Ding; Haitao Lv
Journal:  Clin Rheumatol       Date:  2016-08-05       Impact factor: 2.980

2.  Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.

Authors:  Judith Sánchez-Manubens; Jordi Antón; Rosa Bou; Estíbaliz Iglesias; Joan Calzada-Hernandez; Sergi Borlan; Clara Gimenez-Roca; Josefa Rivera
Journal:  Rheumatol Int       Date:  2016-05-23       Impact factor: 2.631

3.  Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.

Authors:  Lorna Stemberger Maric; Ivica Knezovic; Neven Papic; Branko Mise; Srdan Roglic; Leo Markovinovic; Goran Tesovic
Journal:  Rheumatol Int       Date:  2014-11-28       Impact factor: 2.631

4.  Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience.

Authors:  Yunjia Tang; Xiang Gao; Jie Shen; Ling Sun; Wenhua Yan
Journal:  J Trop Pediatr       Date:  2016-02-15       Impact factor: 1.165

Review 5.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

6.  Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.

Authors:  Yunjia Tang; Wenhua Yan; Ling Sun; Qiuqin Xu; Yueyue Ding; Haitao Lv
Journal:  Clin Rheumatol       Date:  2018-01-12       Impact factor: 2.980

7.  Challenges in early diagnosis of Kawasaki disease in the pediatric emergency department: differentiation from adenoviral and invasive pneumococcal disease.

Authors:  Lorna Stemberger Maric; Neven Papic; Mario Sestan; Ivica Knezovic; Goran Tesovic
Journal:  Wien Klin Wochenschr       Date:  2018-02-23       Impact factor: 1.704

8.  Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease.

Authors:  Kee Hyun Cho; Soo Jung Kang
Journal:  Korean Circ J       Date:  2014-09-25       Impact factor: 3.243

9.  Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.

Authors:  Min Kyu Kim; Min Seob Song; Gi Beom Kim
Journal:  Korean Circ J       Date:  2017-11-09       Impact factor: 3.243

10.  Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age.

Authors:  Hyun Kyung Bae; Do Kyung Lee; Jung Hyun Kwon; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2014-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.